Predicting outcome in the idiopathic glomerulopathies

Journal of Nephrology

Volumn 11, Issue 2, 1998, Pages 57-60

  Cattran, Daniel ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Glomerulonephritis; Outcome; Prediction; Validation

Indexed keywords

CREATININE;

ALGORITHM; CHRONIC KIDNEY FAILURE; CREATININE CLEARANCE; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; IDIOPATHIC DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PREDICTION; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; REGRESSION ANALYSIS; REVIEW; TREATMENT OUTCOME;

GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; LINEAR MODELS; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0031968085     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Bright R. Reports of medical cases. London: Longmans Green, 1827; 75-84.
2. Frerichs FT. Die Bright'sche Nierenkranheit undderen Behandlung. Braunschweig, Vieweg, 1851.
3. Mitch WE, Walser M, Buffington GA, Lemann J. A simple method of estimating progression of chronic renal failure. Lancet 1976; 2: 1326-7.
4. Shaban SA. Change point problem and two-phase regression: An annotated bibliography. Int Stat Rev 1980; 48: 83-93.
5. Jones RH, Molitoris BA. A statistical mehtod for determining the breakpoint of two lines. Analyt Biochem 1984; 141: 287-90.
6. Zoccali C, Postorino M, Martorano C, Salnitro F, Maggiore Q. The "breakpoint" test, a new statistical method for studying progression of chronic renal failure. Nephrol Dial Transplant 1989; 4: 101-4.
7. Sackett D, Haynes B, Tugwell P. Interpretation of diagnostic data. In: Clinical epidemiology - a basic science for a clinical medicine. Little Brown and Company, 1985; 59-138.
8. Friedman LM, Furberg CD, DeMets DL. Sample size. In: fundmentals of clinical trials, 2nd ed. Littleton, PSG Publishing Company Inc., 1985; 83-107.
9. BMDP Statistical software: logistic regression analysis. In: BMDP statistical software manual. Berkeley: University of California Press, 1985; 330-42.
10. SAS Institute: Statistical Analysis System, Version 5.18. SAS Institute, 1985.
11. Sheehe PR. Prognostic modeling of clinical outcomes: an illustration with data from patients with membranous nephropathy. Epidemiology 1991; 2: 339-47.
12. Miller ME, Hui SL, Tierney WM. Validation techniques for logistic regression models. Stat in Med 1991; 10: 1213-26.
13. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982; 247: 2543-6.
14. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993; 119: 474-81.
15. Mark DB, Lam LC, Lee KL, et al. Identification of patients with coronary disease at high risk for loss of employment. Circulation 1992; 86: 1485-94.
16. Talcott JA, Siegel RD, Finber R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992; 10: 316-22.
17. Dickson ER, Murtaugh PA, Wiesner RH, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103: 1893-901.
18. Coiffier B, Gisselbrecht C, Vose JM, et al. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. J Clin Oncol 1991; 9: 211-9.
19. Cattran DC, Pei Y, Greenwood CMT, Ponticelli C, Passerini P, Honkanen E. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 1997; 51: 901-7.
20. Iwane M, Palensky J, Plante K. A user's review of commercial sample size software for design of biomedical studies using survival data. Controlled Clinical Trials 1997; 18: 65-83.
21. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-72.
22. Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int 1986; 29: 1215-23.
23. Webb NJA, Lewis MA, Iqhal J, Smart PJ, Lendon M, Postlethwaite RJ. Childhood steroid-sensitive nephrotic syndrome: does the histology matter? Am J Kidney Dis 1996; 27: 484-8.
24. Couser WG. Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988; 11: 449-64.
25. Cameron JS. Endocapillary exudative glomerulonephritis. In: Shrier RW, Gottschalk CW, eds. Diseases of the kidney 1996; 2: 1948-53.
26. Giani M, Damiani B, Ghio L, Spano M, Edefonti A. Clinical features and prognosis in childhood IgA nephropathy. Renal Failure 1994; 16: 629-36.
27. Packham DK, Yan HD, Hewitson TD, et al. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy. Clin Nephrol 1996; 46: 225-9.
28. Greevska L, Polenakovic M. Tubular and interstitial lesions and mononuclear cell infiltration in primary forms of glomerulonephritis. Renal Failure 1993; 15: 485-93.
29. Skiiki H, Nishino T, Uyama H, et al. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS).Clin Nephrol 1996; 46: 362-8.
30. Schwartz MM, Korbet SM, Rydell J, Borok R, Genchi R. Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants. Am J Kidney Dis 1995; 25: 845-52.
31. Lichtig C, Ben-Izhak O, On A, Levy J, Allon U. Childhood minimal change disease and focal segmental glomerulosclerosis: a continuous spectrum of disease? Pathologic study of 33 cases with long-term folow-up. Am J Nephrol 1991; 11: 325-31.
32. Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigatioon of 220 cases. Nephron 1990; 55: 242-50.
33. Wehrmann M, Bohle A, Bogenschutz O, et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 1989; 31: 67-76.
34. Zent R, Nagai R, Cattran DC. Idiopathic membranous nephropathy in the elderly: a comparative study. Am J Kidney Dis 1997; 29: 200-6.
35. Bakir AA, Share DS, Levy PS, Arruda, Dunea G. Focal segmental glomerulosclerosis in adult African Americans. Clin Nephrol 1996; 46: 306-11.
36. Wyatt RJ, Kritchevsky SB, Woodford SY, et al. IgA nephropathy: long-term prognosis for pediatric patients. J Pediatrics 1995; 127: 913-9.
37. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 1995; 43: 84-8.
38. Honkanen E, Tornroth T, Gronhagen-Riska C, Sankila R. Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted. Clin Nephrol 1994; 41: 127-34.
39. Johnston PA, Brown JS, Braumholtz DA, Davison AM. Clinicopathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Quart J Med 1992; 84: 619-27.
40. Ingulli E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatric Nephrol 1991; 5: 393-7.
41. Linne T, Berg U, Bohman SO, Sigstrom L. Course and long-term outcome of idiopathic IgA nephropathy in children. Pediatric Nephrol 1991; 5: 383-6.
42. Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y. IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol 1990; 10: 191-7.
43. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990; 33: 115-22.
44. Dobronravov VA. Factors predicting chronic renal failure in membranoproliferative glomerulonephritis. Klinicheskaia Meditsina 1996; 74: 29-33.
45. Gonzalo A, Gallego A, Rivera M, Gallego N, Ortuno J. Progression of renal failure in chronic primary glomerular diseases. Nephron 1994; 68: 32-7.
46. Pedersen RS. Long-term prognosis in idiopathic membranoproliferative glomerulonephritis. Scandinavian J Urology & Nephrol 1995; 29: 265-72.
47. Kang SW, Choi KH, Park JH, et al. Prognostic factors and renal survival rates in IgA nephropathy. Yonsei Medical J 1995; 36: 45-52.
48. Toth T, Takebayashi S. Factors contributing to the outcome in 100 adult patients with idiopathic membranous glomerulonephritis. Int Urology & Nephrol 1994; 26: 93-106.
49. Bohle A, Wehrmann M, Bogenschutz O, et al. The long-term prognosis of primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathology, Research & Practice 1992; 188: 908-24.
50. Brahm M, Brammer M, Balslov JT, et al. Prognosis in glomerulonephritis. III. A longitudinal analysis of changes in serum creatinine and proteinuria during the course of disease: effect of immunosuppressive treatment. Report from Copenhagen Study Group of Renal Disease. J Int Med 1992; 231: 339-47.
51. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991; 18: 12-9.
52. Pei Y, Cattran DC, Greenwood C. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 1992; 42: 960-6.
53. Lewis EJ. Idiopathic membranous nephropathy - to treat or not to treat (Editorial). N Engl J Med 1993; 329: 127-9.
54. Cattran DC. Cytotoxics, cyclosporine and membranous nephropathy. Curr Opion in Nephrol and Hypertens 1996; 5: 427-36.
55. Central Committee of the Toronto Glomerulonephritis Registry: Regional program for study of glomerulonephritis. Can Med Asso J 1981; 124: 158-61.
56. Cattran DC, Greenwood C, Ritchie S, et al. For the Canadian Glomerulonephritis Study Group. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 1995; 47: 1130-5.
57. Falk RJ, Hogan SL, Muller KE, Jennette C, and the Glomerular Disease Collaborative Network. Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosamide and corticosteroids with corticosteroids alone. Ann Intern Med 1992; 116: 438-45.
58. Pei Y, Scholey J, Thai K, Suzuki M, Cattran D. Association of angiotensinogengene T235 variant with progression of IgA nephropathy in Caucasion patients. J Clin Invest 1997; 100: 814-20.